Fundraising Fox
/Companies
Sign in

Perthera

Founded 2012 · 17 employees on LinkedIn · 1 known investors

Find your way into Perthera

Perthera provides an AI-powered precision medicine platform for oncologists that analyzes multi-omic molecular data and patient medical history to match cancer patients with targeted therapy options. The platform delivers clinical decision support and real-world evidence to guide personalized cancer treatment.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Investors · 1

Founder mafia

2 people who came through Perthera went on to found or lead other companies.

Yuri FraymanMember Of The Board Of AdvisorsFounded Zenedge +1Andrew MignattiChief Executive OfficerFounded Careviso

In the news

Alliance and Perthera Partner to Deliver Precision Treatment Options to Improve Patient Survival | Colorectal Cancer Alliancecolorectalcancer.org · Apr 2021Perthera Using $8.7M Funding Round to Expand Reach of Cancer Analysis Service | GenomeWebgenomeweb.com · Jul 2016Perthera Secures $8.7 Million Investment From Pilot Growth Equity To Expand Global Leadership In Precision Cancer Analysis ("PCA") - BioSpacebiospace.com · Jun 2016Precision Cancer Analysis Company Perthera Raises $8.7M - FinSMEsfinsmes.com · Jun 2016Perthera Raises $8.7M in Series A Funding | GenomeWebgenomeweb.com · Jun 2016

Frequently asked questions

What does Perthera do?
Perthera provides an AI-powered precision medicine platform for oncologists that analyzes multi-omic molecular data and patient medical history to match cancer patients with targeted therapy options. The platform delivers clinical decision support and real-world evidence to guide personalized cancer treatment.
Who are Perthera's investors?
Perthera's investors include Pilot Growth Equity.